Skip to main content

Table 2 CTTN relative magnitude of the three groups

From: Cortactin is a sensitive biomarker relative to the poor prognosis of human hepatocellular carcinoma

Group n x ¯ ± SE Minimal value Maximal value 95%CI
Control 20 6.54 ± 0.96 1.00 15.72 4.53-8.56
No cancer embolus and metastasis 52 7.75 ± 0.70 1.15 20.35 6.34-9.16
Cancer embolus or metastasis 25 19.73 ± 2.02 2.99 42.47 15.56-23.90
  1. Levene test of homogeneity of variance: F = 10.57, P <0.001; Kruskal-Wallis H test: H = 31.13, P <0.001.